All times shown are PDT (GMT-7) (San Francisco)

Displaying One Session

USAID, IAS, STOP TB Partnership

Pre-Conference USAID, IAS, STOP TB Partnership
Room
Pre-Conference Channel 2
Date
Tue, Jun 30, 2020
Time
08:15 AM - 09:00 AM
Organizer
USAID, IAS, STOP TB Partnership
Pre-Conference Title
Turning threats into opportunities: implementing and advancing quality TB services for people living with HIV during the COVID-19 pandemic and beyond
Pre-Conference USAID, IAS, STOP TB Partnership

Full Session Recording

Duration
20 Minutes
Room
Pre-Conference Channel 2
Organizer
USAID, IAS, STOP TB Partnership
Pre-Conference Title
Turning threats into opportunities: implementing and advancing quality TB services for people living with HIV during the COVID-19 pandemic and beyond
Pre-Conference USAID, IAS, STOP TB Partnership

Human rights of, and community response for and by, PLHIV and affected by TB at the time of COVID-19 - Presentation 1

Duration
5 Minutes
Room
Pre-Conference Channel 2
Organizer
USAID, IAS, STOP TB Partnership
Pre-Conference Title
Turning threats into opportunities: implementing and advancing quality TB services for people living with HIV during the COVID-19 pandemic and beyond
Pre-Conference USAID, IAS, STOP TB Partnership

Human rights of, and community response for and by, PLHIV and affected by TB at the time of COVID-19 - Presentation 2

Duration
5 Minutes
Room
Pre-Conference Channel 2
Organizer
USAID, IAS, STOP TB Partnership
Pre-Conference Title
Turning threats into opportunities: implementing and advancing quality TB services for people living with HIV during the COVID-19 pandemic and beyond
Pre-Conference USAID, IAS, STOP TB Partnership

Live Panel Discusssion: Overcoming stigma, discrimination and other barriers to accessing healthcare for TB, HIV and COVID-19

Duration
35 Minutes
Room
Pre-Conference Channel 2
Organizer
USAID, IAS, STOP TB Partnership
Pre-Conference Title
Turning threats into opportunities: implementing and advancing quality TB services for people living with HIV during the COVID-19 pandemic and beyond